C 455
Alternative Names: C-455Latest Information Update: 28 Oct 2024
Price :
$50 *
At a glance
- Originator AstraZeneca
- Class Hepatoprotectants; Small molecules
- Mechanism of Action AMP activated protein kinase stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Non-alcoholic steatohepatitis
Most Recent Events
- 28 Oct 2024 No recent reports of development identified for preclinical development in Non-alcoholic-steatohepatitis in United Kingdom (IV)
- 28 Oct 2024 No recent reports of development identified for preclinical development in Non-alcoholic-steatohepatitis in United Kingdom (PO)
- 21 Sep 2020 Preclinical trials in Non-alcoholic steatohepatitis in United Kingdom (IV)